2-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells

被引：9

作者：

Serbian, Immo ^{[1
]}

Siewert, Bianka ^{[2
]}

Al-Harrasi, Ahmed ^{[3
]}

Csuk, Rene ^{[1
]}

机构：

[1] Martin Luther Univ Halle Wittenberg Organ Chem, Kurt Mothes Str 2, D-06120 Halle, Saale, Germany

[2] Univ Innsbruck, Inst Pharm Pharmacognosy, CMBI, Ctr Chem & Biomed, Innrain 80-82, A-6020 Innsbruck, Austria

[3] Univ Nizwa, Nat & Med Sci Ctr, POB 33, Birkat Al Mauz 616, Nizwa, Oman

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2019年 / 180卷

关键词：

Maslinic acid; Triterpenoids; Acylation; Cytotoxicity; Apoptosis; IN-VITRO; TRITERPENES; PROLIFERATION; DERIVATIVES; PATTERN;

D O I：

10.1016/j.ejmech.2019.07.049

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Depending on the conditions of the reactions, maslinic acid can be converted into the corresponding 2-O-, 3-O-, or 2,3-di-O-acylated compounds in good yields. These compounds showed in SRB assays a significantly increased cytotoxicity as compared to the parent compound maslinic acid. For the most active compound of this series, i.e. 2-O-(2-chlorobenzoyl) maslinic acid (5), more detailed cell biological tests (i.e. AO/PI dye exclusion experiments, an annexin V assay, and microscopic investigations) on A2780 (human ovarian carcinoma cells) revealed that this compound triggers apoptosis. (C) 2019 Elsevier Masson SAS. All rights reserved.

引用

页码：457 / 464

页数：8

共 50 条

[21] RETRACTED: Pleuromutilin Inhibits Proliferation and Migration of A2780 and Caov-3 Ovarian Carcinoma Cells and Growth of Mouse A2780 Tumor Xenografts by Down-Regulation of pFAK2 (Retracted Article)
Zhang, Bo
Ma, Xiaoli
Li, Yuan
Li, Sijing
Cheng, Jiumei
MEDICAL SCIENCE MONITOR, 2020, 26
[22] ELEVATED EXPRESSION OF THYMIDYLATE SYNTHASE CYCLE GENES IN CISPLATIN-RESISTANT HUMAN OVARIAN-CARCINOMA A2780 CELLS
SCANLON, KJ
KASHANISABET, M
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (03) : 650 - 653
[23] Altered sphingolipid metabolism in N-(4-hydroxyphenyl)retinamide-resistant A2780 human ovarian carcinoma cells
Prinetti, A
Basso, L
Appierto, V
Villani, MG
Valsecchi, M
Loberto, N
Prioni, S
Chigorno, V
Cavadini, E
Formelli, F
Sonnino, S
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) : 5574 - 5583
[24] Chaetomugilin J Enhances Apoptosis in Human Ovarian Cancer A2780 Cells Induced by Cisplatin Through Inhibiting PinkI/Parkin Mediated Mitophagy
Hu, Xiaoqing
Wang, Jiabin
Chai, Jiannan
Yu, Xiaoya
Zhang, Yunhan
Feng, Yuqi
Qin, Jianchun
Yu, Huimei
ONCOTARGETS AND THERAPY, 2020, 13 : 9967 - 9976
[25] Free and N-(2-hydroxypropyl)methacrylamide copolymer-bound geldanamycin derivative induce different stress responses in A2780 human ovarian carcinoma cells
Nishiyama, N
Nori, A
Malugin, A
Kasuya, Y
Kopecková, P
Kopecek, J
CANCER RESEARCH, 2003, 63 (22) : 7876 - 7882
[26] Effect of Spindle Checkpoint on Akt2-mediated Paclitaxel-resistance in A2780 Ovarian Cancer Cells
周婷
鲍引娣
叶双梅
翁丹卉
陈刚
卢运萍
马丁
王世宣
Current Medical Science, 2010, (02) : 206 - 211
[27] Effect of spindle checkpoint on Akt2-mediated paclitaxel-resistance in A2780 ovarian cancer cells
Ting Zhou
Yindi Bao
Shuangmei Ye
Danhui Weng
Gang Chen
Yunping Lu
Ding Ma
Shixuan WANG
Journal of Huazhong University of Science and Technology [Medical Sciences], 2010, 30 : 206 - 211
[28] Salidroside induces apoptosis in human ovarian cancer SKOV3 and A2780 cells through the p53 signaling pathway
Yu, Ge
Li, Na
Zhao, Yan
Wang, Wei
Feng, Xiao-Ling
ONCOLOGY LETTERS, 2018, 15 (05) : 6513 - 6518
[29] Effect of Spindle Checkpoint on Akt2-mediated Paclitaxel-resistance in A2780 Ovarian Cancer Cells
Zhou, Ting
Bao, Yindi
Ye, Shuangmei
Weng, Danhui
Chen, Gang
Lu, Yunping
Ma, Ding
Wang, Shixuan
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2010, 30 (02) : 206 - 211
[30] Discovering simple phenylboronic acid and benzoxaborole derivatives for experimental oncology - phase cycle-specific inducers of apoptosis in A2780 ovarian cancer cells
Psurski, Mateusz
Lupicka-Slowik, Agnieszka
Adamczyk-Wozniak, Agnieszka
Wietrzyk, Joanna
Sporzynski, Andrzej
INVESTIGATIONAL NEW DRUGS, 2019, 37 (01) : 35 - 46

← 1 2 3 4 5 →